Lisa F. Newcomb, PhD, on active surveillance for prostate cancer
October 14th 2024"My hope is that the results of our study improve the uptake of active surveillance, further reducing unnecessary treatments, and this, combined with the improving reflex tests, may change the risk-benefit of PSA screening," says Lisa F. Newcomb, PhD.